Home
Conditions
Urinary Bladder Neoplasms

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

1,227 public trials 271 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Recruiting

Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors

NCT06630416

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, MTAP Deletion, +16 more
Locations: Northwestern University Chicago, Illinois, United States

Northwestern Medicine Orland Park Orland Park, Illinois, United States

View Trial Details

Recruiting

DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr

NCT04106115

Conditions: Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations: Cambridge University NHS FT Cambridge, United Kingdom

Guy's and St Thomas' NHS Foundation Trust London, United Kingdom

Royal Free London NHS FT London, United Kingdom

The Royal Marsden NHS Foundation Trust London, United Kingdom

View Trial Details

Recruiting

Local Radiotherapy for Urinary Bladder Cancer in Patients Not Eligible for Curative Treatment

NCT07524426

Conditions: Bladder Cancer (BC), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Norrlands University Hosital Umeå, Västerbotten County, Sweden

View Trial Details

Recruiting

FAPI and FDG PET/MRI in Diagnosis and Therapy Prediction of Bladder Cancer

NCT06421142

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations: first hospital affiliated of Fujian medical university Fuzhou, Fujian, China

View Trial Details

Recruiting

Trop2-targeted immunoPET Imaging of Solid Tumors

NCT06851663

Conditions: Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +64 more
Locations: Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai, China

View Trial Details

Recruiting

The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy

NCT06388720

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: National Cancer Center Goyang-si, South Korea

View Trial Details

Recruiting

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

NCT07475403

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: The Second Hospital of Tianjin Medical University Tianjin, China

Tianjin Hospital Tianjin, China

Xingtai People's Hospital Xingtai, China

View Trial Details

Recruiting

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

NCT07602010

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations: Oslo University Hospital Oslo, Norway

View Trial Details

Recruiting

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

NCT06503146

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +57 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

T1G3R-1 Trial: Detectability and Prognostic Value of ctDNA in T1 G3 Bladder Cancer

NCT07581496

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Universitätsspital Basel Basel, Switzerland

Luzerner Kantonsspital Lucerne, Switzerland

View Trial Details

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms trial results

Related conditions